- Home
- SQNS vs GRCE Comparison
SQNS vs GRCE Comparison
Compare SQNS & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- GRCE
- Stock Information
- Founded
- SQNS 2003
- GRCE 2002
- Country
- SQNS France
- GRCE United States
- Employees
- SQNS N/A
- GRCE N/A
- Industry
- SQNS Semiconductors
- GRCE
- Sector
- SQNS Technology
- GRCE
- Exchange
- SQNS Nasdaq
- GRCE NYSE
- Market Cap
- SQNS 46.5M
- GRCE 42.1M
- IPO Year
- SQNS 2011
- GRCE N/A
- Fundamental
- Price
- SQNS $1.43
- GRCE $2.98
- Analyst Decision
- SQNS Strong Buy
- GRCE Strong Buy
- Analyst Count
- SQNS 1
- GRCE 1
- Target Price
- SQNS $7.50
- GRCE $12.00
- AVG Volume (30 Days)
- SQNS 977.3K
- GRCE 54.5K
- Earning Date
- SQNS 08-22-2025
- GRCE 06-23-2025
- Dividend Yield
- SQNS N/A
- GRCE N/A
- EPS Growth
- SQNS N/A
- GRCE N/A
- EPS
- SQNS 2.16
- GRCE N/A
- Revenue
- SQNS $38,858,000.00
- GRCE N/A
- Revenue This Year
- SQNS N/A
- GRCE N/A
- Revenue Next Year
- SQNS $93.87
- GRCE N/A
- P/E Ratio
- SQNS $0.68
- GRCE N/A
- Revenue Growth
- SQNS 40.06
- GRCE N/A
- 52 Week Low
- SQNS $0.95
- GRCE $1.75
- 52 Week High
- SQNS $4.28
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- SQNS 37.63
- GRCE N/A
- Support Level
- SQNS $1.26
- GRCE N/A
- Resistance Level
- SQNS $2.33
- GRCE N/A
- Average True Range (ATR)
- SQNS 0.20
- GRCE 0.00
- MACD
- SQNS -0.05
- GRCE 0.00
- Stochastic Oscillator
- SQNS 18.69
- GRCE 0.00
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.